German-speaking memory clinics: State of the art and practical recommendations;Erkennung und behandlung der demenz in den Deutschsprachigen memory-kliniken: Empfehlungen für die praxis

Zeitschrift fur Gerontologie und Geriatrie

Volumn 36, Issue 3, 2003, Pages 189-196

  Diehl, Janine ^a   Staehelin, H ^k   Wiltfang, J ^b   Hampel, H ^k   Calabrese, P ^c   Monsch, A ^k   Schmid, R ^d   Romero, B ^e   Schunk, M ^f   Kuhlmann, H P ^g   Wolter Henseler, D K ^h   Mauerer, C ⁱ   Stoppe, G ^j   Kurz, A ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d Memory Klinik Entlisberg   (Germany)

^e Neurologische Klinik   (Germany)

^f Klinikum am Europakanal   (Germany)

^g Gerontopsychiatrisches Zentrum   (Germany)

^h Westf Klin F Psychiat Psychother   (Germany)

ⁱ Klin fur Psychiat/Psychotherapie   (Germany)

^j UNIVERSITY OF GÖTTINGEN   (Germany)

^k NONE

more..

Author keywords

Memory clinic

Indexed keywords

APHASIA; AUSTRIA; CAR DRIVING; CAREGIVER; COGNITIVE DEFECT; CONFERENCE PAPER; DEMENTIA; GENERAL PRACTITIONER; GENETIC COUNSELING; GERMANY; HUMAN; MEDICAL SPECIALIST; MEMORY; PSYCHIATRIST; PSYCHOLOGICAL ASPECT; SWITZERLAND;

EID: 0141819875     PISSN: 09486704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00391-003-0154-5     Document Type: Conference Paper

References (28)

1. Aarsland D, Laake K, Larsen JP, Janvin C (2002) Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry 72:708-712
2. American-Psychiatric-Association (1994) Diagnostic and statistical manual of mental disorders. Fourth Edition. DSM-IV. American Psychiatric Association, Washington
3. Arzneimittelkommission der Deutschen Ärzteschaft (2001) Empfehlungen zur Therapie der Demenz. Arzneiverordnung in der Praxis Sonderheft
4. Coleman P (1988) Issues in the therapeutic use of reminiscence with elderly people. In: Gearing B, Johnson M, Heller T (eds) Mental Health Problems in Old Age. Wiley, Chichester, pp 177-184
5. Dilllng H, Mombour W, Schmidt MH, Schulte-Markwort E (1994) Weltgesundheitsorganisation: Internationale Klassifikation psychischer Störungen. ICD-10 Kapitel V(F) Forschungskriterien. Huber, Bern Göttingen Toronto Seattle
6. Doody RS, Stevens JC, Beck C et al (2001) Practice parameter: management of dementa (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56:1154-1166
7. Erkinjuntti T, Kurz A, Gauthier S, Bullock R, Damaraju SLV (2002) Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 359:1283-1290
8. Ermini-Fünfschilling D, Meier D (1995) Gedächtnistraining: Wichtiger Bestandteil der Milieutherapie bei seniler Demenz. Z Gerontol Geriat 28:190-194
9. Folstein MF, Folstein SE, McHugh PR (1975) 'Mini Mental State'. A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 12:189-198
10. Fratiglioni L, Wang HX, Ericsson K, Maytan M, Winblad B (2000) Influence of social network on occurrence of dementia: a community-based longitudinal study. Lancet 355:1315-1319
11. Ihl R, Grass-Kapanke B, Lahrem P et al (2000) Entwicklung und Validierung eines Tests zur Früherkennung der Demenz mit Depressionsabgrenzung (TFDD). Fortschr Neurol Psychiat 68:413-422
12. Jick H, Zornberg GL, Jick SS, Seshadri S, Drachman DA (2000) Statins and the risk of dementia. Lancet 356:1627-1631
13. Kaschel R, Zaiser-Kaschel H, Mayer K (1992) Realitä ts-Orientierungs-Training: Literaturüberblick und Implikationen für die neuropsychologische Gedächtnisrehabilitation. Z Gerontopsychol Psychiat 5:223-235
14. Kessler J, Calabrese P, Kalbe E, Berger F (2000) DemTect: Ein neues Screening-Verfahren zur Unterstützung der Demenzdiagnostik. Psycho 26:1-4
15. Laux G (2002) Psychiatric disorders and fitness to drive an automobile. An overview. Nervenarzt 73(3):3231-238
16. McGeer PL, Schulzer M, McGeer EG (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimers disease: a review of 17 epidemiologic studies. Neurology 47:425-432
17. McKeith I, Del-Ser T, Spano P et al (2000) Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 356:2031-2036
18. Morris JC (1993) The clinical dementia rating (CDR) Current version and scoring rules. Neurology 43:2412-2414
19. Pratt R (2002) Patient populations in clinical trials of the efficacy and tolerability of donepezil in patients with vascular dementia. J Neurol Sci 15:203-204
20. Romero B (1997) Selbst-Erhahungs-Therapie (SET): Betreuungsprinzipien, psychotherapeutische Interventionen und Bewahren des Selbstwissens bei Alzheimer Kranken. In: Weis S, Weber G (eds) Handbuch Morbus Alzheimer. Psychologie Verlags Union, Weinheim, pp 1209-1251
21. Sano M, Ernesto C, Thomas RG et al (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. New Engl J Med 336:1216-1222
22. Shulman K, Dold D et al (1993) Clock-Drawing and dementia in the community: a longitudinal study. Int J Geriätr Psychiätry 8:487-496
23. Stoppe G, Staedt J (1999) Psychopharmakotherapie von Verhaltens-stö rungen bei Demenzkranken. Z Gerontol Geriat 32:153-158
24. Thalmann B, Monsch AU (1997) CERAD. The consortium to establish a registry for Alzheimer's disease. Neuropsychologische Testbatterie. Memory Clinic, Basel
25. Wächtler C (2001) Milieutherapie statt Neuroleptika? Zum Stellenwert milieutherapeutischer Maßgnahmen in der Gerontopsychiatrie und speziell bei Demenzkranken. Krankenhaus-psychiatrie 12:125-128
26. Wilson R, Mendes de Leon CF, Barnes L et al (2002) Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA 287(6):742-748
27. Wolozin B, Kellman W, Rousseau P, Celesia GG, Siegel G (2000) Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methylglutaryl conezyme A reductase inhibitors. Arch neurol 57:1439-1443
28. Zandi P, Carlson M, Plassman B et al (2002) Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 288(17):2123-2129